NCT05261880

Brief Summary

To rule out the effects bone mobilization and neural mobilization in Carpal Tunnel Syndrome.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
42

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Mar 2021

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2021

Completed
12 months until next milestone

First Submitted

Initial submission to the registry

February 20, 2022

Completed
10 days until next milestone

First Posted

Study publicly available on registry

March 2, 2022

Completed
28 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 30, 2022

Completed
2 days until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2022

Completed
Last Updated

June 1, 2022

Status Verified

May 1, 2022

Enrollment Period

1.1 years

First QC Date

February 20, 2022

Last Update Submit

May 31, 2022

Conditions

Outcome Measures

Primary Outcomes (3)

  • Visual analogue scale

    A Visual Analogue Scale is a measurement instrument that tries to measure a characteristic or attitude that is believed to range across a continuum of values and cannot easily be directly measured. It is often used in epidemiologic and clinical research to measure the intensity or frequency of various symptoms.

    12th Week

  • Dynamometer

    It is a small device that the examiner holds against the patient's limb as the patient exerts a maximal force. The examiner counters the force "make test", or tries to break the contraction "break test".

    12th Week

  • Boston questionnaire

    The Boston Carpal Tunnel Score is a patient-reported questionnaire that examines symptom severity and overall functional status of patients with carpal tunnel syndrome.

    12th Week

Study Arms (2)

Neural mobilization

EXPERIMENTAL

Neural mobilization will be given for 15 minutes with 3 repetitions. After mobilization, Kinesio taping will be applied and it will bandage till the next session.

Other: Neural mobilization

Scaphoid, hamate mobilization

EXPERIMENTAL

Scaphoid and hamate mobilization for 20 minutes, at the end of session kinesio taping will bandage till the next session.

Other: Scaphoid , hamate mobilization

Interventions

Neural mobilization and bone are two common physical therapy interventions used for Carpal Tunnel Syndrome. Neural mobilization reinstates the plasticity of the nervous system and restoring the capacity of stretching.

Neural mobilization

Bone mobilization in Carpal Tunnel Syndrome involves gliding at scaphoid and hamate.

Scaphoid, hamate mobilization

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • At median nerve distribution, felt pain and parasthesia Phalen sign positive Tinel sign positive Increase symptoms throughout the night Symptoms that continue for at least 3 weeks

You may not qualify if:

  • Pregnancy Diabetes Thyroid disease Rheumatoid arthritis Thenar muscle atrophy Weakness of thenar muscle Hand surgery/ bone fracture

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ripah International University

Faisalabad, Punjab Province, 38000, Pakistan

Location

MeSH Terms

Conditions

Carpal Tunnel Syndrome

Condition Hierarchy (Ancestors)

Median NeuropathyMononeuropathiesPeripheral Nervous System DiseasesNeuromuscular DiseasesNervous System DiseasesNerve Compression SyndromesCumulative Trauma DisordersSprains and StrainsWounds and Injuries

Study Officials

  • Muhammad Kashif

    Riphah International University

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
The study will be single blinded as assessors of the study would be kept blind of the treatment group to which patient will allocated.
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 20, 2022

First Posted

March 2, 2022

Study Start

March 1, 2021

Primary Completion

March 30, 2022

Study Completion

April 1, 2022

Last Updated

June 1, 2022

Record last verified: 2022-05

Data Sharing

IPD Sharing
Will not share

Locations